Skip to Main Content

Describe the newer anti-thrombotic agents, e.g. fondaparinux, direct thrombin inhibitors, antiplatelet drugs and thrombolytic agents

Level

This learning outcome is a primary level outcome.

Sessions

This learning outcome is taught in the following sessions:

Cardiorespiratory 2 (Year 2)
- Lecture: Venous Thromboembolism

Assessment

This learning outcome is assessed in the following ways:

NOT YET CATEGORISED